Sireesh Appajosyula

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Sireesh Appajosyula
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sireesh Appajosyula:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tharimmune, Inc. CEO, Director Common Stock 64,868 $92,112 $1.42 20 Jun 2025 Direct
Hepion Pharmaceuticals, Inc. Director Common Stock, par value $0.0001 per share 1,250,000 $50,000 $0.0400 21 Apr 2026 Direct
Tharimmune, Inc. CEO, Director Stock Option 225,962 03 Nov 2025 Direct
Tharimmune, Inc. CEO, Director Options (right to buy) 115,962 13 Jan 2025 Direct

Insider Reports Filed by Sireesh Appajosyula

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HEPA Hepion Pharmaceuticals, Inc. 21 Apr 2026 1 +$50,000 4 Director 27 Apr 2026, 06:24
HEPA Hepion Pharmaceuticals, Inc. 16 Mar 2026 0 $0 3 Director 18 Mar 2026, 17:20
THAR Tharimmune, Inc. 03 Nov 2025 1 $0 4 CEO, Director 05 Nov 2025, 20:57
THAR Tharimmune, Inc. 04 Aug 2025 1 $0 4 CEO, Director 06 Aug 2025, 17:04
THAR Tharimmune, Inc. 20 Jun 2025 2 +$90,973 4 Chief Executive Officer, Director 23 Jun 2025, 19:31
THAR Tharimmune, Inc. 14 Jan 2025 1 $0 4 Chief Operating Officer, Director 14 Jan 2025, 16:38
THAR Tharimmune, Inc. 13 Nov 2024 1 +$10,096 4 Chief Operating Officer, Director 13 Nov 2024, 17:06
THAR Tharimmune, Inc. 08 Oct 2024 1 +$9,650 4/A Chief Operating Officer, Director 09 Oct 2024, 09:58
THAR Tharimmune, Inc. 09 Aug 2024 1 +$9,650 4 Chief Operating Officer, Director 08 Oct 2024, 16:10
THAR Tharimmune, Inc. 09 Aug 2024 1 $0 4 Chief Operating Officer, Director 12 Aug 2024, 17:18
THAR Tharimmune, Inc. 07 Nov 2022 1 $0 4 Director 09 Nov 2023, 19:52
THAR Hillstream BioPharma Inc. 14 Jul 2022 2 $0 4 Director 18 Jul 2022, 16:15
THAR Hillstream BioPharma Inc. 21 Mar 2022 1 $0 4 Director 23 Mar 2022, 16:15
THAR Hillstream BioPharma Inc. 11 Jan 2022 0 $0 3 Director 11 Jan 2022, 20:48
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .